Pharmacy retailer Dis-Chem saw double-digit headline earnings growth and upped its dividend, but rising operational costs grew at a faster rate than its revenue growth in its year to end-February.
Excluding Covid-19 vaccines, its revenue growth increased 9%, with wholesale revenue from its medicine distribution business up 10.4% to R24.2bn...A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and TimesLive Premium.